MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer

BACKGROUND: The methylation of microtubule-associated protein tau (MAPT) was first described in patients with Alzheimer’s disease. In this study, we aim to determine if MAPT promoter CpG island is hypermethylated and whether this signature could work as a prognostic marker for patients with stage II...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chuntao, Liu, Yanliang, Guo, Wenyi, Zhu, Xu, Ahuja, Nita, Fu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689138/
https://www.ncbi.nlm.nih.gov/pubmed/31496795
http://dx.doi.org/10.2147/CMAR.S206731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689138/
https://www.ncbi.nlm.nih.gov/pubmed/31496795
http://dx.doi.org/10.2147/CMAR.S206731

Ejemplares similares